DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.

The DRAGON registry aims to collect data on combined portal and hepatic vein embolization (PVE/HVE) for liver tumors, a technique expected to enhance liver regeneration compared to standard PVE. This collaborative registry focuses on identifying associations between baseline clinical/imaging parameters, clinical outcomes, and safety for patients undergoing PVE/HVE.

NCT Number	NCT07717437
Lead Sponsor	Maastricht University Medical Center
Conditions	Liver Cancer, Liver Metastases
Enrollment	350 participants
Start Date	2021-03-16
Primary Completion	2027-11-30 (estimated)
Study Completion	2032-11-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-21